Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Yamanouchi team presents series of novel anticoagulants

Dec. 30, 2004

PTC develops compounds for diseases related to nonsense mutations of mRNA

Dec. 30, 2004

Contrast agents claimed by Fuji Photo Film

Dec. 30, 2004

Protein tyrosine phosphatase-1B inhibitors for diabetes

Dec. 29, 2004

Scientists at Takeda prepare and test RFRP receptor antagonists

Dec. 29, 2004

PPAR modulators disclosed in a patent

Dec. 29, 2004

Daiichi researchers test novel compounds for the treatment of cancer

Dec. 29, 2004

Sankyo team isolates antidiabetic compound from a natural source

Dec. 29, 2004

Pfizer team reports series of PPAR agonists for dyslipidemia, hypercholesteremia, etc.

Dec. 28, 2004

Novel agents for treatment of hepatitis C infection described in a patent

Dec. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...